Cargando…

Transcriptome analysis of fasudil treatment in the APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer’s disease

Alzheimer's disease (AD) is the most common cause of progressive dementia. In the present study, we showed hippocampal tissue transcriptome analysis in APPswe/PSEN1dE9 (APP/PS1, AD model) mice treated with fasudil (ADF) and compared with AD mice treated with saline (ADNS) and wild type mice (WT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Hailong, Yan, Yuqing, Gao, Ye, Zhang, Nianping, Kumar, Gajendra, Fang, Qingli, Li, Ziqing, Li, Jiehui, Zhang, Yuna, Song, Lijuan, Wang, Jiawei, Sun, Jingxian, Zhang, Han-Ting, Ma, Cun-Gen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033779/ https://www.ncbi.nlm.nih.gov/pubmed/35459923 http://dx.doi.org/10.1038/s41598-022-10554-9

Ejemplares similares

Inhibition of Rho Kinase by Fasudil Ameliorates Cognition Impairment in APP/PS1 Transgenic Mice via Modulation of Gut Microbiota and Metabolites
por: Yan, Yuqing, et al.
Publicado: (2021)

Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice
por: Ma, Jing, et al.
Publicado: (2017)

Ginseng gintonin attenuates the disruptions of brain microvascular permeability and microvascular endothelium junctional proteins in an APPswe/PSEN-1 double-transgenic mouse model of Αlzheimer's disease
por: Jang, Minhee, et al.
Publicado: (2021)

PSEN1ΔE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia
por: Konttinen, Henna, et al.
Publicado: (2019)

Distinct Rab7-related Endosomal–Autophagic–Lysosomal Dysregulation Observed in Cortex and Hippocampus in APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease
por: Ba, Li, et al.
Publicado: (2017)

Fasudil in Combination With Bone Marrow Stromal Cells (BMSCs) Attenuates Alzheimer’s Disease-Related Changes Through the Regulation of the Peripheral Immune System
por: Yu, Jiezhong, et al.
Publicado: (2018)

Crocetin attenuates inflammation and amyloid-β accumulation in APPsw transgenic mice
por: Zhang, Jin, et al.
Publicado: (2018)

Effect of Fasudil on remyelination following cuprizone‐induced demyelination
por: Wang, Jing, et al.
Publicado: (2019)

Longitudinal Assessment of Working Memory Performance in the APPswe/PSEN1dE9 Mouse Model of Alzheimer’s Disease Using an Automated Figure-8-Maze
por: van Heusden, Fran C., et al.
Publicado: (2021)

Retraction: Effect of Fasudil on remyelination following cuprizone‐induced demyelination.
por: Wang, Jing, et al.
Publicado: (2020)

FSD-C10, a Fasudil derivative, promotes neuroregeneration through indirect and direct mechanisms
por: Li, Yan-Hua, et al.
Publicado: (2017)

Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
por: Hsu, Simon, et al.
Publicado: (2020)

APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines
por: Xiao, Xuewen, et al.
Publicado: (2021)

The influence of fasudil on renal proximal tubular cell epithelial–mesenchymal transition induced by parathormone
por: Gao, Ziqing, et al.
Publicado: (2017)

Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
por: Wang, Qing, et al.
Publicado: (2022)

Mitochondrial biogenesis mediated by melatonin in an APPswe/PS1dE9 transgenic mice model
por: Song, ChaoYuan, et al.
Publicado: (2018)

Intravenous Delivery of Targeted Liposomes to Amyloid-β Pathology in APP/PSEN1 Transgenic Mice
por: Tanifum, Eric A., et al.
Publicado: (2012)

Tetrahydrohyperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing
por: Inestrosa, N C, et al.
Publicado: (2011)

APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease
por: Giau, Vo Van, et al.
Publicado: (2019)

Amyloid-β(1–43) cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
por: Perrone, Federica, et al.
Publicado: (2020)

From EST to structure models for functional inference of APP, BACE1, PSEN1, PSEN2 genes
por: Aathi, Muthusankar, et al.
Publicado: (2019)

Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice
por: François, Arnaud, et al.
Publicado: (2014)

nAChRs gene expression and neuroinflammation in APPswe/PS1dE9 transgenic mouse
por: D’Angelo, Chiara, et al.
Publicado: (2021)

Effects of proton radiation on evoked and spontaneous neuronal activity in the hippocampus of APP/PSEN1 transgenic mice
por: Rudobeck, Emil, et al.
Publicado: (2014)

Combination of fasudil and celecoxib promotes the recovery of injured spinal cord in rats better than celecoxib or fasudil alone
por: Hou, Xiao-lin, et al.
Publicado: (2015)

Oleracone F Alleviates Cognitive Impairment and Neuropathology in APPswe/PSEN1dE9 Mice by Reducing the Expression of Vascular Cell Adhesion Molecule and Leukocyte Adhesion to Brain Vascular Endothelial Cells
por: Kwon, Young-Sun, et al.
Publicado: (2023)

FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity
por: Xin, Yan-Le, et al.
Publicado: (2015)

The associations of APP , PSEN1 , and PSEN2 genes with Alzheimer's disease: A large case–control study in Chinese population
por: Xiao, Xuewen, et al.
Publicado: (2022)

Nasal delivery of Fasudil‐modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis
por: Guo, Shang‐De, et al.
Publicado: (2019)

The influence of GAPT extraction on synapse loss of APPswe/PS1dE9 transgenic mice via adjusting Bcl-2/Bax balance
por: Shi, Jing, et al.
Publicado: (2018)

YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice
por: Wang, Xiaowan, et al.
Publicado: (2017)

Publisher Correction: nAChRs gene expression and neuroinflammation in APPswe/PS1dE9 transgenic mouse
por: D’Angelo, Chiara, et al.
Publicado: (2021)

Neuronal Dynamics and miRNA Signaling Differ between SH-SY5Y APPSwe and PSEN1 Mutant iPSC-Derived AD Models upon Modulation with miR-124 Mimic and Inhibitor
por: Garcia, Gonçalo, et al.
Publicado: (2021)

Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012)

Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro
por: Raut, Snehal, et al.
Publicado: (2021)

Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy
por: Li, Xu-Ying, et al.
Publicado: (2021)

Selective inhibitors of the PSEN1–gamma-secretase complex
por: Serneels, Lutgarde, et al.
Publicado: (2023)

Pathogenic Aβ production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1
por: Kurth, Vanessa, et al.
Publicado: (2023)

Correction: Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012)

Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer’s disease
por: Xu, Lin-Lin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hlqvract2ehhelgi32dmm9u4t1